Thu 11 Nov 2002Galen's results beat market expectationsNorthern Irish pharmaceutical group Galen has reported a strong set of full-year results, beating market expectations.The Craigavon-based company said earnings per share before exceptional items increased by nearly 38 per cent to 32.2 pence (50.7 cents) per share, some 8-10 per cent ahead of forecasts.